Collegium Pharmaceutical (COLL) Cash from Operations (2014 - 2026)

Collegium Pharmaceutical's Cash from Operations history runs 13 years deep, the most recent figure standing at 57113000.0 for Q1 2026.

• In Q1 2026, Cash from Operations rose 3.1% year-over-year to 57113000.0; the TTM figure through Mar 2026 stood at 331038000.0 (up 66.82% YoY), while the FY2025 annual figure was 329323000.0, up 60.66% from the prior year.
• Cash from Operations was 57113000.0 for Q1 2026 at Collegium Pharmaceutical, down from 123048000.0 in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of 123048000.0 in Q4 2025 to a low of 25315000.0 in Q1 2022.
• Historically, Cash from Operations has averaged 58258529.41 across 5 years, with a median of 66325000.0 in 2022.
• The sharpest annual moves came in 2022 and 2025: Cash from Operations slumped 223.07% in 2022, then jumped 971.63% in 2025.
• A 5-year view of Cash from Operations shows it stood at 66325000.0 in 2022, then climbed by 10.57% to 73338000.0 in 2023, then gained by 15.42% to 84644000.0 in 2024, then jumped by 45.37% to 123048000.0 in 2025, then plunged by 53.58% to 57113000.0 in 2026.
• The last three Cash from Operations figures came in at 57113000.0 (Q1 2026), 123048000.0 (Q4 2025), and 78438000.0 (Q3 2025), per Business Quant data.